15.01.2020 | An invert triangle merger transaction, under which EU Bio Pharm controlled by Manor Gindi and Kfir Gindi, will merge into Cannomed Medical Cannabis Industries Ltd.
Over the past days an invert triangle merger transaction has been signed under which EU Bio Pharm, which is controlled by Manor Gindi and Kfir Gindi, would be merged into Cannomed Medical Cannabis Industries Ltd., a publicly traded company.
Upon completion of the merger, Gindi Group will have control of Cannomed.
Manor Gindi and Kfir Gindi were represented by our firm, through Adv. Tomer Altman, partner and Head of Securities Practice and Adv. Racheli Zilberfarb-Schreiber from the Commercial Department.
For the review:
The translation was executed courtesy of Tomedes Translations